The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Johnson & Johnson/Janssen
Stock and Other Ownership Interests - Johnson & Johnson
Amivantamab compared with real-world therapies in patients with NSCLC with EGFR Exon 20 insertion mutations who have progressed after platinum doublet chemotherapy.
 
Anna Rachel Minchom
Honoraria - Bayer; Chugai Pharma; Faron Pharmaceuticals; Merck; Novartis Pharmaceuticals UK Ltd.
Consulting or Advisory Role - Janssen Oncology
Research Funding - Seagen
Travel, Accommodations, Expenses - Amgen
 
Nicolas Girard
Employment - AstraZeneca (I)
Consulting or Advisory Role - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Lilly; MSD; Novartis; Pfizer; Pharmamar; Roche; Sanofi; Takeda
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; MSD Oncology; Roche
 
Lyudmila Bazhenova
Stock and Other Ownership Interests - Epic Sciences
Consulting or Advisory Role - AstraZeneca; Bayer; BeyondSpring Pharmaceuticals; Blueprint Medicines; BMSi; Boehringer Ingelheim; Daichi; G1 Therapeutics; Genentech/Roche; Johnson and Johnson; Merck; neuvogen; Novartis; Regeneron; Takeda
Research Funding - BeyondSpring Pharmaceuticals
 
Sai-Hong Ignatius Ou
Stock and Other Ownership Interests - Elevation Oncology; Turning Point Therapeutics
Honoraria - ARIAD/Takeda; AstraZeneca; Genentech/Roche; Pfizer; Roche Pharma AG
Consulting or Advisory Role - AstraZeneca; Janssen; Pfizer; Roche/Genentech; Takeda
Speakers' Bureau - AstraZeneca; Genentech/Roche
Research Funding - ARIAD (Inst); AstraZeneca (Inst); AstraZeneca/MedImmune (Inst); Janssen (Inst); Mirati Therapeutics (Inst); Pfizer (Inst); Revolution Medicines (Inst); Roche Pharma AG (Inst)
 
Shirish M. Gadgeel
Honoraria - AstraZeneca; Genentech/Roche; Merck
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Daichii-Sanyko; Eisai; Genentech/Roche; Janssen Oncology; Jazz Pharmaceuticals; Lilly; Novartis; Novocure; Pfizer; Puma Biotechnology; Takeda; Xcovery
Research Funding - Amgen (Inst); ARIAD/Takeda (Inst); Astellas Pharma (Inst); AstraZeneca; AstraZeneca (Inst); Blueprint Medicines (Inst); Daiichi Sankyo (Inst); Genentech/Roche (Inst); I-Mab (Inst); Lycera (Inst); Merck; Merck (Inst); Nektar (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Genentech/Roche; Merck
Other Relationship - AstraZeneca
 
José Trigo
Consulting or Advisory Role - BMS; Boehringer Ingelheim; Merck Serono; Takeda
Speakers' Bureau - AstraZeneca; Merck Serono; MSD Oncology; Roche
Travel, Accommodations, Expenses - AstraZeneca; BMS; MSD Oncology
 
Santiago Viteri
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen; Roche
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Roche
Travel, Accommodations, Expenses - MSD
 
Daniel Backenroth
Employment - Johnson & Johnson/Janssen
Stock and Other Ownership Interests - Johnson & Johnson
 
Archan Bhattacharya
Employment - Johnson & Johnson/Janssen
Stock and Other Ownership Interests - Johnson & Johnson
 
Tracy Li
Employment - Johnson & Johnson/Janssen
Stock and Other Ownership Interests - Johnson & Johnson
 
Parthiv Mahadevia
No Relationships to Disclose
 
Joshua Bauml
Consulting or Advisory Role - AstraZeneca; Ayala Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Foundation Medicine; Genentech; Guardant Health; Inivata; Janssen; Merck; Novartis; Novartis; Regeneron; Takeda
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Carevive Systems (Inst); Incyte (Inst); Janssen (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Takeda (Inst)